Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Khaudeja Bano

Khaudeja Bano

Senior Medical Director, Abbvie USA

Akwete Lex Adjei

Akwete Lex Adjei

Executive Director, Rhodes Pharmaceuticals USA

Hayam Atteya

Hayam Atteya

Faculty of Medicine,Cairo Universit Egypt

Ehab Darwish

Ehab Darwish

Medical Director, TopLab Egypt

Global Pharmacovigilance 2017

Sessions/Tracks

ConferenceSeries Ltd organizing splendorous Pharmaceutical conferences welcomes you to attend the 8thGlobal Pharmacovigilance & Drug Safety Summit to be held during July 6-8, 2017 in Kuala Lumpur, Malaysia  focuses on the advancements in pharmacovigilance and risk management.

The field of Pharmacovigilance is growing by and large, its development is making high impact in field of Pharmaceuticals and medical sciences. 8th Global Pharmacovigilance & Drug Safety Summit focusses on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence..The main theme of 8th Global Pharmacovigilance & Drug Safety Summit is "Innovations in Pharmacovigilance for Systematic Safety and Management"

Track-1: Drug Safety:

Drug Safety or Pharmacovigilance (PV or PhV), is the  study of Pharmacology  related to the data collection, assessment, detection,  monitoring, and prevention of adverse effects with drug products. In this Track we will discuss about  Drug safety awith its importance in various fields as Training, softwares etc. & other topics which are  discussed in Pharmacovigilance Conferences

Related conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain

Track-2: Adverse Drug Reactions:

Adverse drug reaction (ADR) can be defined as damage caused by taking a medication. Most of the adverse drug reactions represent an enhancement of the drug's therapeutic effects. There are various types of Adverse Drug Reactions and its effect on the body. Proper assessment and reporting of adverse drug reactions is important for drug safety systems. In this track we will focus on Expected and un-expected drug reactions and its reporting. Even drug product manufacturers, professionals, and consumers can report Post marketing reportson adverse effects & other topics which are discussed in Pharmacovigilance Conferences

Related Conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain

Track 3: Pharmacovigilance Significance&Scope:

The focus in the track named Pharmacovigilance and its Significance and Scope will be on importance of pharmacovigilance. It will help to analyze its potential as a major discipline within medical science, and to find out its influence on patient health and public welfare. This will help to better understand what is pharmacovigilance. In  Pharmacovigilance Practice we will come to know about Pharmacovigilance legislation, the rules and laws to follow. Pharma Industries have a major role in the improvement of Pharmacovigilance system to maintain the safety data.  Pharmacovigilance Conferences also deals with  Ecopharmacovigilance (EPV), pharmacoenvironmentology and pharmacovigilance in herbal medicines.

Related Conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain

Track 4: Continental Pharmacovigilance:

Continental Pharmacovigilance provides a scope  to ensure compliance with local and international requirements, to operate more efficiently across various regions and health authorities.

Related Conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain

Track 5: Good Pharmacovigilance Practice:

Pharmacovigilance and Pharmacoepidemiology role in the risk management mainly focusses on  to overcome  insufficient evidence of safety from clinical trials. Good Pharmacovigilance  Practice avoids major problems in risk management which are discussed in Pharmacovigilance Conferences. It is of high importance to focus  on Signal investigation via observational studies and Interpreting safety signals. Concentrating on dosages forms in random clinical trials is very important. The Pharmacovigilance clinical trials service providing companies should have the Pharmacovigilance certification .

Related Conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain

Track-6: Pharmacovigilance and Risk Management:

Pharmacovigilance and Risk Management play a major role in Drug Industry. The new turn in Drug Industry is to use Information technology in pharmacovigilance companies. Drug industry needs to promote companies in pharmacovigilance Practice and the Review of Softwares used in Pharmacovigilance and Clinical Trials. Monitoring of  unlicensed, off labels and orphan drugs is major task in risk management. In this conferences so many experts from different Pharmacovigilance CRO's ,pharmacovigilance service providers are participating to shares their knowledge and discuss about the new updates.

Related Conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain

Track-7: Pharmacokinetics and Pharmacodynamics:

Drugs at various steps undergo, Pharmacokinetics and Pharmacodynamics and toxicity testing through animal testing. These tests allow researchers to allometrically find out a safe starting dose of the drug for clinical trials in humans. This track will be  revolving around  Advances in Pharmacodynamic Interactions, Drug and substance abuse, Drug-drug interactions. Also discussion will be about the Pharmacy Practices to maintain the Pharmacokinetics and Pharmacodynamics, its Challenges and its guidelines. There are several challenges in compounding and dispensing practice in Pharmacokinetics and Pharmacodynamics which are also covered inPharmacovigilance Conferences

Related Conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain


Track 8: Pre-Clinical and Clinical Trials:

The main goals of Pre-Clinical and Clinical Trials are to determine the safe dose and start to assess product's safety profile. In Designing of trials there are pre-clinical studies and different phases of clinical trials. In this trails they estimate the Bioassay and its types. The Data collection and quality control is the major part in Pre-Clinical and Clinical Trials. For some specific drugs there are some Alternative trials designs and models are used. Pre-Clinical and Clinical Trials are conducted as Multi center trials and monitoring basis. Each Pre-Clinical and Clinical Trials study of a drug, biological product, or medical device regulated by the FDA must be reviewed, approved, and monitored by the Regulatory authorities and ethics committee. There are several types of clinical trials like Clinical trials on drugs used in respiratory disorders. Advanced Information technology in clinical trials improves the quality of Pre-Clinical and Clinical Trials which are a part of Pharmacovigilance Conferences

Related Conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain

Track-9: Clinical Trials on Various Disorders:

Clinical Trials on Drugs used in Various Disorders, Pharmacotherapy and Pharmacotherapeutics Emerging technology in clinical trials track mainly deals on the clinical trials in long chronic diseases and several disorders. In This track we will be discussing about the Recent clinical trials on AIDS, Clinical trials on benign and malignant tumours, Clinical trials on cardiovascular diseases, Clinical trials on diabetes, Clinical trials of monoclonal and polyclonal antibodies, Clinical trials on drugs used in psychological disorders The current research mainly focuses on Applications of biomarkers in clinical trials. These are a part of Pharmacovigilance Conferences.

Related Conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain

Track-10: Clinical Research and Statistics:

In Clinical Research Statistics plays major role. Depends upon the Statistics the clinical trials go for regulatory submissions. There are several guidelines mainly ICH guidelines for clinical research and its statistics follow for the clinical research. Stastical analysis of past pharmacovigilance conferences and adverse drug reactions reports also consider for the regulatory submission.

 

Related Conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain

Track-11: Case Report in Clinical Trials:

Case Report in Clinical Trials plays major role in clinical research. In this track focus will be  about the several case reports like Cancer case reports, Cardiovascular trials case report, Case studies on sexually transmitted diseases, Case studies on type 1 and type 2 diabetes, Case reports on drugs used in pregnancy and lactation.

Related Conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain

 

Track-12: Biopharmaceutics:

In Clinical Pharmacology and Bio pharmaceutics track discussion will be about the Rational drug management of cancer, diabetes and cardiovascular disorders, and Management of psychiatric disorders and autoimmune disorders. Along with clinical trials Bioavailability and bioequivalence studies also plays major role in clinical research.

Related Conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain

 

Track-13: PV Data Base Management:

There is advantage in centralising all safety data, clinical data, analysis and reporting with one provider.Pharmacovigilance Software tool provides comprehensive analysis of adverse events arising from the use of pharmaceutical products (Medicinal Product, Medical Device, Vaccines, Non-Drug Therapy and Veterinary Medicinal Product). The drug safety database allows the risk- benefit analysis of medicinal products taking into account new and emerging information, in the context of cumulative information. Pharmacovigilance since beginning has been a compliance driven activity, wherein your regulatory compliance determines company’s risk assessment scores. A drug safety database offers scheduling of alerts for expedited cases, follow-up cases and PSUR/PADER reports submission to meet regulatory timeline compliance. PV database is also covered in Pharmacovigilance Conferences

Related Conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain

 

Track-14: PV Consulting’s and Business opportunity:

Due to the changing resources necessary to fulfil the regulatory requirements, some companies also choose to outsource or out task regulatory affairs to external service providers. Regulatory Affairs department is constantly evolving and growing and is the one which is least impacted during the Acquisition and Merger, and also during recession. The stringent regulations on safety monitoring and their periodical revision have led to increasedsafety data collection, analysis and regulatory surveillance, and increased costs. Thus, Pharmacovigilance has become a critical phase in clinical development programs.

Related Conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain

 

Track-15: Regulatory affairs:


Regulatory affairs for clinical trials is the major part in the clinical trials approaches. Every clinical trial must be conduct according to the Regulatory affairs guidelines. There are several Regulatory affairs depending upon the countries. Regulatory Affairs departments are growing within companies. Global harmonization in standards has led to consistent approach in regulatory submissions and hence its review.

Related Conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain


Track-16: Growth strategies in Pharma:

Strategies for Growth in Pharma Environment track mainly focused in Strategic development towards FDA approval and Post market product surveillances. The updates and advances in pharmacovigilance regulationsystem will be discussed in Advances in changing pharmacovigilance regulation system track. These strategies are covered in the Pharmacovigilance Conferences

Related Conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain

Track-17: Pharmacy Practices and its Challenges:

In Pharmacy Practices and its Challenges track mainly focused on Pharmacy practice and its guidelines and Challenges in compounding and dispensing practice. Dosage regimen, drug toxicity and drug safety measures place important position in clinical research.

Related Conferences:

8th Asian Biosimilars Congress, August 14-16, 2017 Osaka, Japan, 11th International Conference on Pharmacoepidemiology and Clinical Research, August 21-23, 2017, Kuala Lumpur, Malaysia, 9th World Congress on BA/BE Studies and Biowaivers, September 18-21, 2017 Kuala Lumpur, Malaysia, 8th Global Pharmacovigilance & Drug Safety Summit,  April 17-18, 2017 Bali, Indonesia, 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea, 8th World Congress on Toxicology and Pharmacology, April 13-15, 2017 Dubai, UAE,  19th International Conference on Advanced Pharmaceutical Engineering and Pharmacology, July 22-23, Porto, Portugal, 18th International Conference on Industrial Pharmacy, December 26-27, 2016, Dubai, UAE, 18th International Conference on Pharmacy and Pharmacology, September 29-30, 2016, 19th International Conference on Pharmacology and Drug Delivery Systems, February 7-8, 2017, Amsterdam, Netherlands, 19th International Conference on Pharmacovigilance and Drug Safety, May 25-26, 2017, London, United Kingdom, 19th International Conference on Ocular Pharmacology and Clinical Pharmacy, January 12-13, 2017, Durban, South Africa. 14th Global Experts Meeting on Nano materials and Nanotechnology,  Mar 30-31, 2017,  Madrid, Spain

About Conference

ConferenceSeries Ltd organizing splendorous Pharmaceutical conferences welcomes you to attend the 8thGlobal Pharmacovigilance Summit to be held during July 6-8, 2017 in Kuala Lumpur, Malaysia, focuses on the advancements in pharmacovigilance and risk management. The field of Pharmacovigilance is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. The main theme of 8th Global Pharmacovigilance Summit is "Innovations in Pharmacovigilance for Systematic Safety and Management".

8th Global Pharmacovigilance & Drug Safety Summit emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.

Why to attend???

With members from around the world focused on learning about Pharmacovigilance and its advances; this is your best opportunity to reach the largest assemblage of participants from the Pharmacovigilance community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Pharmacovigilance are hallmarks of this conference.

Target Audience:

  • Pharmacovigilance Students, Scientists
  • Pharmacovigilance Researchers
  • Pharmacovigilance Faculty
  • Medical Colleges
  • Pharmacovigilance Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies

 

Market Analysis

Global Pharmacovigilance Market is expected to reach USD 5.51 billion by 2020, according to a new study by Grand View Research, Inc. Increasing incidence rates of adverse drug reaction and the introduction of stringent drug safety regulations are some key drivers of this market. ADR is responsible for approximately 5% of the hospitalization in developed countries annually, and this is expected to boost usage rates over the next six years. Pharmacovigilance has witnessed a significant rise in usage rates in the recent times owing to growing global geriatric population triggering a growth in demand for new drug development. Additionally, health regulatory authorities such as the U.S. FDA and EMEA (European Medicines Agency) are now emphasizing on electronic submission of data which is also expected to drive the pharmacovigilance market.

Contract outsourcing pharmacovigilance market is expected to grow at a lucrative rate of over 13.1% during the forecast period. Service flexibility and cost effectiveness associated with outsourcing are some key factors accounting for the segment’s lucrative growth.

Further key findings from the study suggest:Global Pharmacovigilance Market is expected to reach USD 5.51 billion by 2020, according to a new study by Grand View Research, Inc. Increasing incidence rates of adverse drug reaction and the introduction of stringent drug safety regulations are some key drivers of this market. ADR is responsible for approximately 5% of the hospitalization in developed countries annually, and this is expected to boost usage rates over the next six years. Pharmacovigilance has witnessed a significant rise in usage rates in the recent times owing to growing global geriatric population triggering a growth in demand for new drug development. Additionally, health regulatory authorities such as the U.S. FDA and EMEA (European Medicines Agency) are now emphasizing on electronic submission of data which is also expected to drive the pharmacovigilance market.

Contract outsourcing pharmacovigilance market is expected to grow at a lucrative rate of over 13.1% during the forecast period. Service flexibility and cost effectiveness associated with outsourcing are some key factors accounting for the segment’s lucrative growth.

  • Pharmacovigilance services found the largest application in phase 4/IV clinical trial studies in 2013. Greater applicability and relevance are some factors accounting for the segment’s market position.
  • Contract outsourcing was the most revenue generating service provider segment in 2013. Minimization of upfront investments and reduction in fixed overhead costs are some factors expected to drive segment growth.
  • North America was the largest regional market, accounting for over 40.0% of the revenue in 2013. Presence of stringent healthcare regulations implemented by the U.S. FDA and high market penetration rates of electronic medical records are some factors responsible for its large share.  
  • Asia Pacific is identified as the most lucrative market. Presence of a large pool of skilled labor and favorable business environments are some factors expected to drive regional market growth. Rapidly improving healthcare infrastructure in the emerging economies of India and China is also expected to provide new growth opportunities to the market participants.
  • Key players of this market include Quintiles Transnational Corporation, PAREXEL International, Clinquest Group BV, Pharmaceutical Product Development, Accenture Plc., Boehringer Ingelheim GmbH and Cognizant Technology Solutions
  • Providing customized end to end PV solutions & services and entering into strategic agreements are some key strategies adopted by these market players.

 

Global pharmacovigilance market, by clinical trials, 2012 – 2020 (USD Million)

 

Past Conference Report

Global Pharmacovigilance 2016

Global Pharmaovigilance 2016 past Conference Report

Thanks to all of our wonderful Speakers, Conference Attendees and Sponsors; Global Pharmacovigilance 2016 Conference was our best ever!

5th Global Pharmacovigilance Summit hosted by the Conference Series LLC was held during April 28-29, 2016 Dubai, UAE at Oberoi Centre, Dubai, UAE with the theme “Ensure safer drugs with healthcare community” which got magnificent response. With the support and guidance of Organizing Committee Members and Editorial Board Members and astonishing presentations of all participants this prominent summit became more impressive.

Conference Series LLC would like to convey a great appreciation to Akwete Lex Adjei as a Keynote speaker.

Akwete Lex Adjei, Rhodes Pharmaceuticals, USA.

Honourable guests and Keynote Speakers supported this event with sustainable excitement for grand success of this prominent conference. Also it is our pleasure to announce next 8th Global Pharmacovigilance & Drug safety Summit which will be held during July 6-8, 2017 in Kuala Lumpur, Malaysia with the theme “Innovations in Pharmacovigilance for Systematic safety and Management”.

We hope your favorable support will make next summit also one more grand success.

For more details about Global Pharmacovigilance 2017 visit

Websitehttp://globalpharmacovigilance.pharmaceuticalconferences.com/


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date July 06-08, 2017

Speaker Opportunity

Supported By

Journal of Pharmacovigilance Journal of Clinical & Experimental Pharmacology Journal of Clinical Trials

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner